Zoetis

$161.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.28 (+0.80%) Today

$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Zoetis and other stocks, options, and ETFs commission-free!

About ZTS

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ. The listed name for ZTS is ZOETIS INC.

CEO

Kristin C. Peck

Employees

10,600

Headquarters

Parsippany, New Jersey

Founded

1952

Market Cap

76.74B

Price-Earnings Ratio

46.13

Dividend Yield

0.50

Average Volume

1.52M

High Today

$162.19

Low Today

$160.29

Open Price

$161.61

Volume

853.30K

52 Week High

$176.64

52 Week Low

$90.14

Collections

Analyst Ratings

60%

of 20 ratings

Buy

60%

Hold

35%

Sell

ZTS Earnings

$0.00

$0.37

$0.73

$1.10

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 11, Pre-Market